Genelux Corp (NASDAQ: GNLX) has experienced a rise in its stock price by 3.20 compared to its previous closing price of 2.81. However, the company has seen a fall of -0.34% in its stock price over the last five trading days. globenewswire.com reported 2024-11-06 that WESTLAKE VILLAGE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at the Guggenheim Inaugural Healthcare Innovation Conference, taking place November 11-13, 2024, in Boston, Massachusetts.
Is It Worth Investing in Genelux Corp (NASDAQ: GNLX) Right Now?
Company’s 36-month beta value is -2.05.Analysts have differing opinions on the stock, with 5 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GNLX is 27.77M, and currently, short sellers hold a 5.16% ratio of that floaft. The average trading volume of GNLX on November 14, 2024 was 156.49K shares.
GNLX’s Market Performance
GNLX’s stock has seen a -0.34% decrease for the week, with a -6.15% drop in the past month and a 43.56% gain in the past quarter. The volatility ratio for the week is 6.91%, and the volatility levels for the past 30 days are at 10.15% for Genelux Corp The simple moving average for the past 20 days is -0.03% for GNLX’s stock, with a -21.50% simple moving average for the past 200 days.
Analysts’ Opinion of GNLX
Many brokerage firms have already submitted their reports for GNLX stocks, with Guggenheim repeating the rating for GNLX by listing it as a “Buy.” The predicted price for GNLX in the upcoming period, according to Guggenheim is $8 based on the research report published on October 29, 2024 of the current year 2024.
ROTH MKM, on the other hand, stated in their research note that they expect to see GNLX reach a price target of $10. The rating they have provided for GNLX stocks is “Buy” according to the report published on August 28th, 2024.
H.C. Wainwright gave a rating of “Buy” to GNLX, setting the target price at $35 in the report published on November 27th of the previous year.
GNLX Trading at 9.12% from the 50-Day Moving Average
After a stumble in the market that brought GNLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.53% of loss for the given period.
Volatility was left at 10.15%, however, over the last 30 days, the volatility rate increased by 6.91%, as shares surge +3.20% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.47% upper at present.
During the last 5 trading sessions, GNLX fell by -0.34%, which changed the moving average for the period of 200-days by -72.59% in comparison to the 20-day moving average, which settled at $2.90. In addition, Genelux Corp saw -79.30% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GNLX starting from Szalay Aladar, who sale 31,777 shares at the price of $2.73 back on Sep 12 ’24. After this action, Szalay Aladar now owns 632,901 shares of Genelux Corp, valued at $86,732 using the latest closing price.
Szalay Aladar, the 10% Owner of Genelux Corp, sale 33,080 shares at $2.57 during a trade that took place back on Sep 13 ’24, which means that Szalay Aladar is holding 599,821 shares at $84,946 based on the most recent closing price.
Stock Fundamentals for GNLX
Current profitability levels for the company are sitting at:
- -18.56 for the present operating margin
- 0.37 for the gross margin
The net margin for Genelux Corp stands at -18.03. The total capital return value is set at -0.69. Equity return is now at value -88.57, with -69.34 for asset returns.
Based on Genelux Corp (GNLX), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -42.89. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -569.06.
Currently, EBITDA for the company is -26.46 million with net debt to EBITDA at 0.22. When we switch over and look at the enterprise to sales, we see a ratio of 65.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.01.
Conclusion
In a nutshell, Genelux Corp (GNLX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
